// App-Quantinova.ai

372 : Expression profiling of circulating tumor cells: A prognostic and predictive biomarker in metastatic breast cancer

Researchers

Presenter

  • Maren Bredemeier

Principal Investigators

  • Mikael Kubista

  • Robert Sjoback

  • Sabine Kasimir-Bauer

  • Marie Jendrichova

  • Eva Rohlova

  • Vednula Novosadova

  • Katarina Kolostova

  • Siegfried Hauch

  • Bahriye Aktas

  • Mitra Tewes

  • Rainer Kimmig

Medical Centers

  • AdnaGen, Langenhagen, Germany

  • Department of Laboratory Genetics, University Hospital Kralovake Vinohrady, Prague, Czech Republic

  • Institute of Biotechnology CAS, Prague, Czech Republic

  • Department of Gynecology and Obstetrics, University Hospital Dresden, Dresden, Germany

  • Department of Surgery, Westgerman Cancer Center, University Hospital Essen, Essen, Germany

  • TATAA Biocenter, Goetheburg, Sweden

Locations

  • Germany

  • Czech Republic

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • beta-2 microglobulin

  • Circulating tumor cells

  • Epidermal growth factor receptor

  • Epithelial Cell Adhesion Molecule

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved